Obicare Oral Disintegrating Film 10mg (Solifenacin Succinate)

Adult dosage

The usual recommended dose for adults (including older adults) is 5mg of solifenacin once daily. If necessary, the dose may be increased to a maximum of 10mg once daily, and may be taken with or without food. This medicine is an orally disintegrating film and is not available in a 5mg strength, so take it only when an increase to 10mg is necessary. Place this medicine on the tongue, allow it to dissolve, and take it without water.

This medication should not be used in patients with symptoms of urinary retention, severe gastrointestinal diseases, myasthenia gravis, or narrow-angle glaucoma. Additionally, it should not be taken by patients undergoing dialysis, those with severe liver dysfunction, severe kidney disorders, or patients with certain genetic disorders. Caution is needed in patients at risk of urinary retention or with increased risk of gastrointestinal obstruction or decreased gastrointestinal motility, and the maximum dosage should be limited in patients with severe kidney impairment or moderate liver impairment. This medication may cause side effects such as dry mouth, constipation, blurred vision, urinary retention, and dry eyes, especially at higher doses. Serious gastrointestinal adverse reactions or angioedema have been reported, and if side effects occur, immediate consultation with a physician is required. Patients with QT prolongation syndrome or hyperkalemia should be careful, as there is a risk of cardiovascular adverse reactions. If angioedema or anaphylaxis occurs, discontinue the medication immediately and seek appropriate treatment. This medication may increase the risk of accidents due to drowsiness or blurred vision when driving or operating machinery. Concurrent use with anticholinergic drugs may enhance effects or worsen side effects, so it must be reported before use, as it may reduce the effectiveness of prokinetic drugs. Co-administration with strong CYP3A4 inhibitors can increase blood concentration of this drug, necessitating dosage adjustments. Pregnant women should be cautious as the safety of this drug during pregnancy has not been established, and nursing mothers should avoid use as it can be secreted in breast milk and affect neonates. Safety and efficacy in children have not been established, so do not administer to pediatric patients. Overdosage may result in symptoms such as headache, dizziness, drowsiness, and blurred vision; appropriate emergency measures should be taken if necessary.

• Dry mouth
• constipation
• blurred vision
• urinary retention
• dry eyes
• nausea
• dyspepsia
• upper abdominal pain
• vomiting
• urinary tract infection

This medication should be stored in a tightly closed container to protect it from air or moisture. It is advisable to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage maintains the drug's efficacy and safety well.

Appearance

Pink rectangular oral film preparation

Package unit

1 sheet/pouch